Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-09-032810
Filing Date
2009-06-30
Accepted
2009-06-30 15:55:53
Documents
2
Period of Report
2009-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - DR. LANGECKER rrd246740.html 3  
1 FORM 3 - DR. LANGECKER rrd246740.xml 3 1515
2 POWER OF ATTORNEY rrd221141_249944.htm EX-24.1 3144
  Complete submission text file 0001181431-09-032810.txt   6461
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O INTARCIA THERAPEUTICS, INC. 2000 POWELL ST., SUITE 1640 EMERYVILLE CA 94608
Business Address
LANGECKER PETER (Reporting) CIK: 0001282829 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 09919251